Davita Inc vs iShares 20 Plus Year Treasury Bond ETF — how do they compare? Davita Inc trades at $179.25 (market cap $11.29B), while iShares 20 Plus Year Treasury Bond ETF trades at $77.98 (market cap $47.61B). The key difference: iShares 20 Plus Year Treasury Bond ETF is far larger — about 4.2× Davita Inc's market cap, and Davita Inc is trading nearer its 52-week high, iShares 20 Plus Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and iShares 20 Plus Year Treasury Bond ETF for 83 Days on average.
| DVA | TLT | |
|---|---|---|
Market Cap | $11.29B | $47.61B |
Volume | 582,204 | 49,263,490 |
Sector | Health | Fixed Income |
52-Week High | $240.96 | $92.06 |
52-Week Low | $103.87 | $77.11 |
Typical Hold Time | 114 Days | 83 Days |
Enterprise Value | $24.01B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, up 0.14% with a bearish technical signal despite recent earnings beats. The stock shows strong profitability with 32.36% gross margins and 635.3% ROE, though net income margin declined to 5.47% in 2025. Recent partnership expansions with Humana for value-based kidney care and institutional buying by BlackRock provide positive catalysts. Valuation appears reasonable with P/E of 15 and P/S of 0.88, below sector averages.
Outlook remains mixed with analyst consensus target of $235.67 suggesting 33% upside, but technical indicators signal near-term caution. Key risks include regulatory pressures on healthcare reimbursements and rising debt-to-asset ratio reaching 65.55%. Earnings momentum from three consecutive quarterly beats supports fundamental strength, though margin compression warrants monitoring.
TLT, the iShares 20+ Year Treasury Bond ETF, trades at $77.87, down 46% over five years amid a historic bond market selloff. The technical outlook is bearish with moving averages signaling continued pressure, while oscillators remain neutral. Recent news highlights Treasury yields reaching multi-decade highs above 5.3%, creating headwinds for long-duration bond funds as investors face elevated interest rate expectations.
The ETF faces significant interest rate risk with the Federal Reserve maintaining higher rates. Current yields above 5% offer attractive income but price depreciation remains a concern. Key risks include prolonged high inflation, further Fed tightening, and economic growth surprises that could extend the bond market downturn.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity greater than or equal to twenty years.
Read more on TLT →